Intelligence desk

Products

Signal Tracker Data Platform Data Enrichment API

Solutions

Deal Origination Executive Search For Sales Teams Corporate Development For Founders For Agencies For Investors Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Start Free
Tethys Bioscience, Inc. logo — company profile

Tethys Bioscience, Inc.

Founded 2002 United States Emeryville, United States 20 employees Debt Financing Total: $75.40M Biotechnology, Health Care

General Information

Company Name Tethys Bioscience, Inc.
Founded Year 2002
Location United States Emeryville, United States +2
Employees 20
Industries Biotechnology, Health Care
Funding Stage Debt Financing
Social

Get notified when Tethys Bioscience, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tethys Bioscience, Inc.

Tethys Bioscience, Inc. was established in 2002 with the mission to create and commercialize innovative blood tests to assess imminent disease risk. Their focus was on reducing the burden of preventable chronic diseases by preempting their development. The company's flagship product, PreDx® Diabetes Risk Score, was a fasting blood test that provided an unprecedented level of risk stratification for patients at risk for type 2 diabetes. Recent studies showed that a decrease in PreDx DRS correlated with a decreased risk of diabetes years later. Tethys aimed to build a sustainable cardiometabolic diagnostics business by expanding its commercial infrastructure and establishing partnerships to increase physician use. However, the company closed its doors in 2014, and its assets were acquired by Human Diagnostics Labs. The last recorded investment was a $12.00M Debt Financing investment on 01 January 2012, led by Armentum Partners. Tethys Bioscience operated in the Biotechnology and Health Care industries and was headquartered in the United States.

Taxonomy: blood tests, disease risk assessment, chronic diseases, cardiometabolic conditions, diabetes risk score, diagnostics business, commercialization, early intervention, preventive healthcare, biomarker analysis, healthcare partnerships

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $12.00M 1
Armentum Partners
01 Jan 2012
Debt Financing $10.00M 2 Silicon Valley Bank, Oxford Finance LLC 21 Jul 2010
Venture Round $23.00M 2
Greenspring Associates
Paul Capital 		21 Jul 2010
Series D $25.00M 5
Kleiner Perkins Mohr Davidow Ventures Intel Capital Wasatch Advisors Aeris Capital
09 Nov 2009
Series C Unknown 4
Kleiner Perkins Greenspring Associates Mohr Davidow Ventures Intel Capital
10 Jan 2008

View All 6 Funding Rounds

Tethys Bioscience, Inc. Alternatives & Competitors

Tethys Bioscience, Inc. vs
Brighter
Brighter

Empowering intelligent chronic care with data-driven insights.

Post Ipo Debt
Biotechnology, Health Care
Tethys Bioscience, Inc. vs
mProbe Inc.
mProbe Inc. United States

At mProbe we are transforming the fields of precision health and precision medicine with molecular d...

17 employees
Biotechnology, Health Care
Tethys Bioscience, Inc. vs
Bio Conscious Technologies Inc.
Bio Conscious Technologies Inc. Canada

Prevention as a Service™

Seed
11 employees
AI, Biotechnology

FAQ About Tethys Bioscience, Inc.

Our Mission To create and commercialize innovative blood tests that accurately assess imminent disease risk, enabling healthcare providers to preempt the onset of chronic cardiometabolic conditions by focusing healthcare resources on those patients who will benefit the most from early and aggressive...
Tethys Bioscience, Inc. was founded in 2002.
Tethys Bioscience, Inc. is headquartered in Emeryville, United States.
Tethys Bioscience, Inc. operates in the following industries: Biotechnology, Health Care.
Tethys Bioscience, Inc. has approximately 20 employees.
Tethys Bioscience, Inc. has completed 6 funding rounds, raising a total of $75.40M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Tethys Bioscience, Inc. include Brighter, mProbe Inc., Bio Conscious Technologies Inc., Fuelbetter, TrackActive. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tethys Bioscience, Inc. and Brighter are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tethys Bioscience, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

Start Tracking — Free

One analytics cookie (Google Analytics). Cookie Policy